High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer

Estela Maria Silva,Vânia Sammartino Mariano,Paula Roberta Aguiar Pastrez,Miguel Córdoba Pinto,António G. Castro,Kari Syrjänen,Adhemar Longatto-Filho

High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer

2017

Estela Maria Silva
Vânia Sammartino Mariano
Paula Roberta Aguiar Pastrez
Miguel Córdoba Pinto
António G. Castro
Kari Syrjänen
Adhemar Longatto-Filho

Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq) [Grant number 401775/2012-7 to ALF]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [Grant number 2014/ 23414-8 to EMS]

Keywords:

Inflammation
Carcinoma
Immunotherapy
Immune system
Cancer research
Interleukin 6
Lung cancer
Medicine
Biomarker (medicine)
in patient
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations